0.05%环孢素滴眼液在干眼治疗中的价值
The Value of 0.05% Cyclosporin Eye Drops in the Treatment of Dry Eyes
DOI: 10.12677/HJO.2023.123015, PDF,    科研立项经费支持
作者: 吴炜纲, 邢冬霞, 杨雪莉*：大理大学第一附属医院眼科，云南 大理
关键词: 干眼；环孢素滴眼液；作用机制；临床应用；Dry Eye Disease； Cyclosporin Eye Drops； Action Mechanism; Clinical Application
摘要: 干眼是一种慢性眼表炎症疾病，主要表现为眼部异物感、干燥感、烧灼感，伴有畏光、视物模糊等眼部不适症状，中重度干眼对日常生活和工作会有严重影响，严重时甚至会引起患者抑郁、焦虑、失眠等精神问题，传统的干眼治疗方法如人工泪液、非甾体类抗炎药等对症处理后效果有限，因此，寻找行之有效的治疗显得尤为重要。该综述主要就0.05%环孢素滴眼液治疗干眼的作用机制和临床应用进行详细阐述。
Abstract: Dry eye is an inflammatory disease of the ocular surface, mainly characterized by foreign body sensation, dryness, burning sensation in the eyes, accompanied by symptoms such as photophobia and blurred vision. Moderate to severe dry eye can have a serious impact on daily life and work, and even cause mental problems such as depression, anxiety, and insomnia in patients. Therefore, effective treatment is particularly important. This review focuses on the mechanism and clinical application of 0.05% cyclosporin eye drops in the treatment of dry eyes.
文章引用：吴炜纲, 邢冬霞, 杨雪莉. 0.05%环孢素滴眼液在干眼治疗中的价值[J]. 眼科学, 2023, 12(3): 108-111. https://doi.org/10.12677/HJO.2023.123015

参考文献

[1] Stapleton, F., Alves, M., Bunya, V.Y., et al. (2017) TFOS DEWS II Epidemiology Report. The Ocular Surface, 15, 334-365.
[Google Scholar] [CrossRef] [PubMed]
[2] Zhang, Y., Chen, H. and Wu, X. (2012) Prevalence and Risk Factors Associated with Dry Eye Syndrome among Senior High School Students in a County of Shandong Province, China. Ophthalmic Epidemiology, 19, 226-230.
[Google Scholar] [CrossRef] [PubMed]
[3] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识: 定义和分类(2020年) [J]. 中华眼科杂志, 2020, 56(6): 418-422.
[4] Bron, A.J., de Paiva, C.S., Chauhan, S.K., et al. (2017) TFOS DEWS II Pathophysiology Report. The Ocular Surface, 15, 438-510.
[Google Scholar] [CrossRef] [PubMed]
[5] De Paiva, C.S., et al. (2019) Topical Cyclosporine A Therapy for Dry Eye Syndrome. Cochrane Database of Systematic Reviews, 3, 78-92.
[Google Scholar] [CrossRef] 
[6] Small, D.S., Acheampong, A., Reis, B., et al. (2002) Blood Concentrations of Cyclosporin A during Long-Term Treatment with Cyclosporin A Ophthalmic Emulsions in Patients with Moderate to Severe Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics, 18, 411-418.
[Google Scholar] [CrossRef] [PubMed]
[7] Sall, K., Stevenson, O.D., Mundorf, T.K., et al. (2000) Two Multicenter, Randomized Studies of the Efficacy and Safety of Cyclosporine Ophthalmic Emulsion in Moderate to Severe Dry Eye Disease. Ophthalmology, 107, 631-639.
[Google Scholar] [CrossRef] 
[8] 杨怡然, 胡皎月, 刘祖国. 环孢素A在干眼治疗中的价值及应用前景[J]. 中华跟科杂志, 2020, 56(10): 787-795.
[9] 田小辉, 胡鹿梅, 易湘龙, 等. 0.05%环孢素A治疗干眼有效性和安全性Meta分析[J]. 国际眼科杂志, 2023, 23(2): 248-255.
[10] Chen, M., Gong, L., Sun, X., et al. (2010) A Comparison of Cyclosporine 0.05% Ophthalmic Emulsion versus Vehicle in Chinese Patients with Moderate to Severe Dry Eye Disease: An Eight-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Trial. Journal of Ocular Pharmacology and Therapeutics, 26, 361-366.
[Google Scholar] [CrossRef] [PubMed]
[11] Kilic, S. and Kulualp, K. (2016) Efficacy of Several Therapeutic Agents in a Murine Model of Dry Eye Syndrome. Comparative Medicine, 66, 112-118.
[12] Gao, J., Schwalb, T.A., Addeo, J.V., et al. (1998) The Role of Apoptosis in the Pathogenesis of Canine Keratoconjunctivitis Sicca: The Effect of Topical Cyclosporin A Therapy. Cornea, 17, 654.
[Google Scholar] [CrossRef] [PubMed]
[13] Moore, C.P., McHugh, J.B., Thorne, J.G., et al. (2001) Effect of Cyclosporine on Conjunctival Mucin in a Canine Keratoconjunctivitis Sicca Model. Investigative Ophthalmology & Visual Science, 42, 653-659.
[14] Wang, Y., Ogawa, Y., Dogru, M., et al. (2008) Ocular Surface and Tear Functions after Topical Cyclosporine Treatment in Dry Eye Patients with Chronic Graft-Versus-Host Disease. Bone Marrow Transplantation, 41, 293-302.
[Google Scholar] [CrossRef] [PubMed]
[15] Chang, H.P., Hyung, K.L., Mee, K.K., et al. (2019) Comparison of 0.05% Cyclosporine and 3% Diquafosol Solution for Dry Eye Patients: A Randomized, Blinded, Multicenter Clinical Trial. BMC Ophthalmology, 19, Article No. 131.
[16] 沈滢滢, 管怀进, 王立新, 沈晓瑛. 玻璃酸钠滴眼液联合兹润环孢素滴眼液对白内障术后中重度干眼症的疗效分析[J]. 海军医学杂志, 2022, 43(9): 978-982.
[17] Wan, K.H., et al. (2015) Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta Analysis. The Ocular Surface, 13, 213-225.
[Google Scholar] [CrossRef] [PubMed]

为你推荐